Comment

NCPDP Comment

  1. Modify the following:

Type- Standard

Standard Implementation/Specification- HL7® FHIR® US Core R.3.0 - Care Plan Profile

Standards Process Maturity – Final

Implementation Maturity- Production

Adoption Level – 3

  1. Modify the following:

Type-Emerging Implementation Specification

Standard Implementation/Specification- HL7® C-CDA on FHIR® Care Plan

Standards Process Maturity – Final

Implementation Maturity- Production

Adoption Level – 1

  1. Add the following:

Type- Emerging Implementation Specification

Standard Implementation/Specification- HL7® FHIR® US Core R.4.0 - Care Plan Profile

Standards Process Maturity – In development

Implementation Maturity- Need Feedback

Adoption Level – Need Feedback

Federally Required - No

Cost - free

Test Tool Availability - No

NCPDP Comment

  1. Add the following:

Type-Emerging Standard

Standard Implementation/Specification- HL7 Implementation Guide for C-CDA Release 2.1: Consolidated CDA for Clinical Notes and C-CDA on FHIR R4

Standards Process Maturity – Final

Implementation Maturity- Production

Adoption Level – 1

Federally Required – No

Cost – $

Test Tool Availability – No

Available – Spring 2020

NCPDP Comment

For NCPDP Pharmacist eCare Plan Version 1.0: Guidance on the Use of the HL7 CDA Consolidated Templates for Clinical Notes R2.1 Care Plan, change Adoption level to Pilot.

Pharmacy HIT Collaborative's Comments on ONC's Proposed 2018 ISA

The Pharmacy HIT Collaborative supports the balloted drafts of HL7 Implementation Guide for CDA Release 2: Consolidated CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use, Release 2.1 and HL7 Resource Care Plan (v3.0.1).  The Collaborative also supports HL7 Fast Healthcare Interoperability Resources (FHIR), STU3, which is in development.

Care Plan Document Type is not Required

HL7 Implementation Guide for CDA® Release 2: Consolidated CDA Templates for Clinical Notes (US Realm), Draft Standard for Trial Use, Release 2.1. 

This should not be listed as required. MU2015 did not require the care plan document. MU2015 did require Concerns and Goals within transition of care documents but not specifically the Care Plan document. The snapshot or visit context of a care plan for transition of care is appropriate. A longitudinal care plan in the form of a CCDA is unwieldly and virtually useless from the perspective of a provider. The longitudinal care plan needs to be in the context of an application for optimal management and viewing.

NCPDP - Comment

  • Add the following:

Type-Implementation Specification

Standard Implementation/Specification- NCPDP Pharmacist eCare Plan Version 1.0: Guidance on the Use of the HL7 CDA Consolidated Templates for Clinical Notes R2.1 Care Plan

Standards Process Maturity – Final

Implementation Maturity- Production

Adoption Level – 2

Federally Required – No

Cost – $

Test Tool Availability – Yes

  • Add the following:

Type-Implementation Specification

Standard Implementation/Specification- NCPDP HL7 CDA® R2 Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm - US Realm

Standards Process Maturity – Final

Implementation Maturity- Production

Adoption Level – 2

Federally Required – No

Cost – $

Test Tool Availability – Yes

  • Add the following:

Type-Implementation Specification

Standard Implementation/Specification- NCPDP HL7 CDA® R2 FHIR Implementation Guide: Pharmacist Care Plan Document, Release 1 - US Realm - US Realm

Comment: FHIR is used to implement the Care Plan. See https://www.healthit.gov/techlab/ipg/node/4/submission/1376

Standards Process Maturity – Final

Implementation Maturity- Pilot

Adoption Level – 1

Federally Required – No

Cost – $

Test Tool Availability – Yes